Geodon is the brand name for ziprasidone hydrochloride, an atypical antipsychotic medication used to treat schizophrenia and bipolar mania [1].
What is Geodon used for?
Geodon (ziprasidone) is prescribed for the treatment of schizophrenia in adults and adolescents 10 years and older [1]. It is also used for acute manic or mixed episodes associated with bipolar I disorder in adults and children 10 years and older [1].
How does ziprasidone work?
Ziprasidone works by affecting dopamine and serotonin neurotransmitters in the brain [1]. It is thought to help manage symptoms of schizophrenia and bipolar disorder by rebalancing these chemicals [1].
When does the patent for Geodon expire?
The patent landscape for Geodon is complex, with multiple patents covering the drug and its formulations. Information on specific patent expiry dates is often tracked by specialized services [2].
Are there generic versions of Geodon available?
Yes, generic versions of ziprasidone are available, which can impact pricing and market competition [3].
What are the potential side effects of Geodon?
Common side effects of Geodon include drowsiness, dizziness, nausea, constipation, and weight gain [1]. More serious side effects can include QT prolongation, a heart rhythm disorder, and neuroleptic malignant syndrome [1]. Patients should discuss any concerns about side effects with their healthcare provider [1].
How does Geodon compare to other antipsychotics?
Ziprasidone is an atypical antipsychotic, a class that also includes medications like risperidone, olanzapine, and quetiapine [4]. These medications differ in their mechanisms of action, side effect profiles, and efficacy for specific symptoms [4]. The choice of antipsychotic is typically individualized based on patient needs and tolerance [4].
Where can I find more information on Geodon patents and market exclusivity?
Detailed information regarding patents, exclusivity periods, and market trends for drugs like Geodon is available through resources like DrugPatentWatch.com [2].